Friday, March 25, 2016 1:23:10 PM
I truly believe their product has major benefits, but there's a large gap between us DIY and having to call their professional services team as it stands. If we can do it quickly in house it's much preferred to relying on vendors.
There are some applications that would be "nice" to virtualize immediately, but VDI and local installs does the job for now, so why bother? If we could do it easily ourselves that would be awesome, but that's not going to happen as it is now. We are much more likely to wait rather than jump onboard an immature technology.
The big clients who have a dire need for this will be the first movers, the smaller players <50 installs will have to come later, TCO isn't that high for them anyways... for 100's or 1000's, that's a different story.
I have a strategic hedged position on Sphere, yes.
Here's another concern: why are you all investing in technology stocks when you can't manage to test it yourself? It only takes a few clicks. Am I the only person here who has actually tested the software or actually understands the technologies involved? No wonder the stock has crashed from 10 to 1.
Stop the insults and sledging and bring me facts. I'm turning here for information that I have yet to discover.. let's share these so we can discuss and come up with a price for this black box.
And p.s. this comment doesn't really fly: "Sphere marketing materials says it works and this supersedes your experience or any other tech expert's insight."
Recent ANY News
- Form 8-K - Current report • Edgar (US Regulatory) • 03/01/2024 09:00:19 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/14/2024 09:31:39 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/12/2024 11:22:03 PM
- Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 02/12/2024 11:18:13 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/08/2024 02:54:40 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 01/29/2024 10:15:40 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 01/26/2024 09:19:16 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/23/2024 01:30:58 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/19/2024 09:30:19 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/17/2024 10:42:53 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/12/2024 12:06:02 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/12/2024 12:03:09 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/11/2024 11:58:51 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 01/05/2024 09:15:49 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/04/2024 09:19:49 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/04/2024 01:30:27 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 01/03/2024 09:07:44 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/20/2023 11:01:50 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/20/2023 11:01:46 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/05/2023 09:44:11 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/05/2023 09:43:58 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 12/05/2023 09:37:58 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/05/2023 09:21:49 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/05/2023 01:04:52 AM
- Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] • Edgar (US Regulatory) • 11/17/2023 10:59:03 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM